|
1. |
Influence of α‐thalassemia trait on spleen function in sickle cell anemia patients with high HbF |
|
American Journal of Hematology,
Volume 53,
Issue 1,
1996,
Page 1-5
A.D. Adekile,
M. Tuli,
M.Z. Haider,
K. Al‐Zaabi,
S. Mohannadi,
A. Owunwanne,
Preview
|
PDF (613KB)
|
|
摘要:
AbstractSpleen function was studied in a group of 20 Kuwaiti SS patients (aged 2–12 years), using99mTc‐labeled tin colloid scintigraphy. They were screened for the α‐thalassemia determinants which are prevalent in the Arabian Peninsula [‐α (3.7 kb) deletion, α2‐globin gene polyadenylation signal (AATAAA → AATAAG) mutation, and 5′ IVS‐I splice junction pentanucleotide (GAGGTGAGG → GAGG) deletion] with a combination of polymerase chain reaction and allele‐specific oligonucleotide (ASO) hybridization techniques. The patients were divided into three groups depending on the result of their colloid uptake. Group I consisted of 7 patients (35.0%) with normally visualized spleens, Group II consisted of 5 (25.0%) with partial visualization, and in Group III there were 8 (40.0%) in whom the spleen was not visualized at all. The significant distinguishing features among those in Groups I and III were mean corpuscular volumes (MCVs) of 74.1 ± 5.1 and 90.1 ± 6.6 fl (P<0.0001) and mean corpuscular hemoglobins (MCHs) of 22.4 ± 2.7 and 27.5 ± 4.0 pg (P<0.05), respectively. The overall frequency of α‐thalassemia determinants in the study was 35.0%; however, the frequencies in Groups I, II, and III were 57.1, 30.0, and 18.8%, respectively. α‐Thalassemia trait, therefore, appears to be associated with normal splenic function in these
ISSN:0361-8609
DOI:10.1002/(SICI)1096-8652(199609)53:1<1::AID-AJH1>3.0.CO;2-V
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1996
数据来源: WILEY
|
2. |
Primary thrombocythemia and pregnancy: Treatment and outcome in fifteen cases |
|
American Journal of Hematology,
Volume 53,
Issue 1,
1996,
Page 6-10
Pasqualepaolo Pagliaro,
Luisa Arrigoni,
Maria Luisa Muggiasca,
Marina Poggio,
Umberto Russo,
Edoardo Rossi,
Preview
|
PDF (403KB)
|
|
摘要:
AbstractPregnancy in patients with primary thrombocythemia (PT) is reported to be often complicated by recurrent abortion and fetal growth retardation. Fifteen pregnancies in nine patients with PT are reported. Nine pregnancies had a good outcome, with the birth of a healthy infant. There were two spontaneous abortions and three intrauterine deaths. One pregnancy was electively terminated after extensive thrombosis in the splanchnic district requiring surgical entero‐resection. In five pregnancies the mother received no treatment; in ten pregnancies acetylsalicylic acid (ASA) was prescribed to the mother as soon as she was found pregnant, subcutaneous heparin was added from the middle trimester in seven cases. In patients treated with ASA and subcutaneous heparin pregnancies had a good outcome. Administration of ASA and heparin during pregnancy appears to improve the outcome in patients with PT and can prevent severe maternal complications, but requires close monitoring. © 1996 Wiley‐Liss,
ISSN:0361-8609
DOI:10.1002/(SICI)1096-8652(199609)53:1<6::AID-AJH2>3.0.CO;2-V
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1996
数据来源: WILEY
|
3. |
Postoperative thrombotic thrombocytopenic purpura following cardiovascular surgeries |
|
American Journal of Hematology,
Volume 53,
Issue 1,
1996,
Page 11-17
Jae C. Chang,
Ash Shipstone,
Marian A. Llenado‐Lee,
Preview
|
PDF (2582KB)
|
|
摘要:
AbstractAmong 47 patients with thrombotic thrombocytopenic purpura (TTP), 8 patients were diagnosed to have postoperative‐TTP. Two patients underwent vascular surgery, 5 patients coronary artery bypass grafts, and 1 patient resection of myocardial sarcoma. Prior to surgery, all patients except one had normal hemograms and platelet counts, and blood smears showed no schistocytes. Five to 19 days after surgery, all 8 patients developed postoperative TTP, which clinical feature was characterized by unexplained progressive encephalopathy, thrombocytopenia, and microangiopathic hemolytic anemia. In addition, in 3 patients, progressive gangrene of the toes also developed. Four patients achieved complete remission following exchange plasmapheresis and 1 patient spontaneous remission. Due to complicated surgical settings after surgery, recognition of TTP was often delayed and it contributed to death in 3 patients despite treatment with exchange plasmapheresis. In view of occurrence of postoperative TTP following cardiac and vascular surgeries, pathogenic mechanism for postoperative TTP may be explained on the basis of injury of diseased endothelial surface and release of a humoral factor(s) that results in platelet aggregation in the capillaries and arterioles. Our experience with these cases indicates that TTP may occur as a serious complication of cardiac and vascular surgeries, and early recognition of the diagnosis and institution of exchange plasmapheresis are of paramount importance for favorable outcome. © 1996 Wiley‐Liss,
ISSN:0361-8609
DOI:10.1002/(SICI)1096-8652(199609)53:1<11::AID-AJH3>3.0.CO;2-8
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1996
数据来源: WILEY
|
4. |
High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children |
|
American Journal of Hematology,
Volume 53,
Issue 1,
1996,
Page 18-21
Shigeto Fuse,
Hideshi Tomita,
Masaki Yoshida,
Tsukasa Hori,
Chiharu Igarashi,
Shigeru Fujita,
Preview
|
PDF (335KB)
|
|
摘要:
AbstractIn several animal experiments, high doses of antithrombin III concentrates have shown beneficial effects on mortality and reversal of coagulation abnormalities which had resulted from disseminated intravascular coagulation. Other experiments have suggested that antithrombin III infusion without heparin is effective in the treatment of organ failure. We clinically treated children suffering disseminated intravascular coagulation only with antithrombin concentrate. Four patients suffering disseminated intravascular coagulation with organ failure were selected. We started antithrombin III concentrate infusion as soon as the diagnosis was established. The dosage of antithrombin III was 120–250 units/kg/day for 2 or 3 days. Heparin was not used. All 4 patients recovered completely and quickly without any complications within 14 days. We suggest that the high‐dose antithrombin III infusion without heparin is an effective and safe therapy for disseminated intravascular coagulation with organ failure. © 1996 Wiley‐Lis
ISSN:0361-8609
DOI:10.1002/(SICI)1096-8652(199609)53:1<18::AID-AJH4>3.0.CO;2-8
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1996
数据来源: WILEY
|
5. |
Mechanism of intravascular hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) |
|
American Journal of Hematology,
Volume 53,
Issue 1,
1996,
Page 22-29
Hideki Nakakuma,
Preview
|
PDF (832KB)
|
|
摘要:
AbstractParoxysmal nocturnal hemoglobinuria (PNH) hemolysis requires both intravascular complement activation and affected erythrocytes susceptible to complement. This susceptibility is explained by a deficiency in complement regulatory membrane proteins that are attached to the membrane by a glycosylphosphatidylinositol (GPI) anchor. Affected cells lack a series of GPI‐anchored membrane proteins with various functions. The lack is caused by a synthetic defect of the anchor due to an impaired transfer ofN‐acetylglucosamine to phosphatidylinositol which is an early metabolic precursor in the anchor synthesis. Moreover,PIG‐Agene responsible for the membrane defect was recently cloned. Further, a possible mechanism of complement activation has been proposed, especially for an infection‐induced hemolytic precipitation which is clinically crucial. Thus, the molecular events, leading to intravascular hemolysis characteristic of PNH, has been virtually clarified. Next major concern is the nature ofPIG‐A:How doesPIG‐Aexplain the complex pathophysiology of PNH which exhibits various clinical manifestations? © 1996 Wil
ISSN:0361-8609
DOI:10.1002/(SICI)1096-8652(199609)53:1<22::AID-AJH5>3.0.CO;2-7
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1996
数据来源: WILEY
|
6. |
Expression of EVI1 and the retinoblastoma genes in acute myelogenous leukemia with t(3;13)(q26;q13–14) |
|
American Journal of Hematology,
Volume 53,
Issue 1,
1996,
Page 30-34
Yuji Yufu,
S. Sadamura,
H. Ishikura,
Y. Abe,
M. Katsuno,
J. Nishimura,
H. Nawata,
Preview
|
PDF (726KB)
|
|
摘要:
AbstractThe EVI1 DNA‐binding protein gene on chromosome 3q26 has been reported to be activated in some leukemia cells with alterations in 3q26. We present an acute myelogenous leukemia (AML) patient with a rare chromosomal translocation, t(3;13)(q26.2;q13–14). By reverse transcription‐ polymerase chain reaction, we detected active transcription of the EVI1 gene in the patient's leukemia cells. The retinoblastoma susceptibility (Rb) gene, a tumor‐suppressor gene, is located at chromosome 13q14 and is within the other translocation breakpoint in this patient. The expression of the Rb gene product was found to be substantially decreased in the patient's leukemia cells by Western blotting. Southern blot analysis, however, revealed no gross abnormalities of the Rb gene. Although it is unlikely that the Rb gene is directly involved in this translocation, the loss of the Rb gene product combined with the activation of the EVI1 gene may have led to the development of leukemia. © 1996 Wiley
ISSN:0361-8609
DOI:10.1002/(SICI)1096-8652(199609)53:1<30::AID-AJH6>3.0.CO;2-6
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1996
数据来源: WILEY
|
7. |
Clinical, genetic, and biochemical features of G‐6PDWest Virginia |
|
American Journal of Hematology,
Volume 53,
Issue 1,
1996,
Page 35-36
Seth J. Corey,
Ernest Beutler,
Preview
|
PDF (145KB)
|
|
摘要:
AbstractA new mutation of the G‐6PD gene at position 910 is described. Biochemical analysis suggests that a conformational change results in the enzymatic deficiency associated with G‐6PDWest Virginia. © 1996 Wiley‐Lis
ISSN:0361-8609
DOI:10.1002/(SICI)1096-8652(199609)53:1<35::AID-AJH7>3.0.CO;2-6
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1996
数据来源: WILEY
|
8. |
Factor V Q 506 mutation in children with thrombosis |
|
American Journal of Hematology,
Volume 53,
Issue 1,
1996,
Page 37-39
Aytemiz Gurgey,
Lutfiye Mesci,
Yavuz Renda,
Lale Olcay,
Nurten Kocak,
Gulsen Erdem,
Preview
|
PDF (209KB)
|
|
摘要:
AbstractThe factor V Leiden mutation in 12 children with thrombosis and in 20 controls was investigated. Five heterozygous individuals and 1 homozygous individual among the cases with thrombosis and 1 heterozygous individual among controls were found. Central nervous system thromboses were increased in children with the factor V mutation, associated with protein S deficiency. © 1996 Wiley‐Liss, I
ISSN:0361-8609
DOI:10.1002/(SICI)1096-8652(199609)53:1<37::AID-AJH8>3.0.CO;2-6
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1996
数据来源: WILEY
|
9. |
Circadian rhythm of serum erythropoietin in multiple myeloma |
|
American Journal of Hematology,
Volume 53,
Issue 1,
1996,
Page 40-42
Paolo Pasqualetti,
Antonio Collacciani,
Raffaele Casale,
Preview
|
PDF (235KB)
|
|
摘要:
AbstractThe diurnal rhythm in the circulating serum levels of erythropoietin (EPO) were determined in a group of 20 adult clinically‐healthy subjects, in a group of 10 patients with myeloma without renal impairment and 10 patients with myeloma and renal failure. Venous blood samples were drawn during the span of a whole day and every 4 hr, starting from midnight, for the measurement of serum EPO levels by radioimmunoassay (RIA). Statistical analysis was carried out by means of the “cosinor” method. Results show that the controls and the myeloma patients without renal insufficiency present significant (P<0.05) circadian rhythms in serum EPO levels; no rhythm (P<0.05) was detected in patients with myeloma and renal failure. Patients with myeloma and renal failure have significant (P<0.05) lower mean daily levels and diurnal fluctuations of EPO than the other groups, whereas the patients with myeloma without renal involvement present higher (P<0.05) mean daily levels and lower (P0.05) exist between the groups regarding peaks of rhythms. These data confirm the existence of a physiological circadian rhythm in serum EPO concentrations, with maximum in the afternoon, and they suggest that renal failure is an important cause of anemia and loss of EPO circadian rhythm in patients with myeloma. © 1996 Wiley‐L
ISSN:0361-8609
DOI:10.1002/(SICI)1096-8652(199609)53:1<40::AID-AJH9>3.0.CO;2-5
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1996
数据来源: WILEY
|
10. |
Absence of CD69 expression on peripheral eosinophils in episodic angioedema and eosinophilia |
|
American Journal of Hematology,
Volume 53,
Issue 1,
1996,
Page 43-45
Mitsuhiro Kawano,
Hiroaki Muramoto,
Shinichiro Tsunoda,
Ichiro Koni,
Hiroshi Mabuchi,
Akihiro Yachie,
Toshio Miyawaki,
Preview
|
PDF (272KB)
|
|
摘要:
AbstractA 45‐year‐old woman with episodic angioedema and eosinophilia is presented. CD69, which is one of the surface antigens of activated eosinophils, was not expressed on the peripheral eosinophils in this patient, in contrast to hypereosinophilic syndrome. This suggests that CD69, which is not dependent on eosinophil density, may be another useful activation marker of eosinophils to distinguish episodic angioedema and eosinophilia from hypereosinophilic syndrome. © 1996 Wiley‐Lis
ISSN:0361-8609
DOI:10.1002/(SICI)1096-8652(199609)53:1<43::AID-AJH10>3.0.CO;2-4
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1996
数据来源: WILEY
|
|